Las Vegas, NV -- (SBWIRE) -- 01/13/2014 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Molycorp Inc (NYSE:MCP), Peregrine Pharmaceuticals (NASDAQ:PPHM), First Horizon National Corporation (NYSE:FHN), Galena Biopharma Inc (NASDAQ:GALE).
Molycorp Inc (NYSE:MCP) ended its recent business day with the advanced of 2.46% and closed at the price of $5.42 after opening at $5.33. The stock traded during its last trading session with the total volume of 6.97 million shares, as compared to its average volume of 8.30 million shares. Molycorp, Inc. produces and sells rare earth and rare metal materials in the United States and internationally.
Will MCP Continue To Move Higher? Find out via this report
Peregrine Pharmaceuticals (NASDAQ:PPHM) remained among the day bullish 4.17% and traded with volume of 4.33 million shares in the last session, as compared to average volume of 2.32 million shares. In comparison with 52 week range of $1.11 - $2.43, it faced lowest price of $1.57 during the last trading session whereas its day highest price was $1.66. The company’s total market capitalization is $260.53 Million, along with 160.33 million shares outstanding. Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of monoclonal antibodies focused on the treatment and diagnosis of cancer.
Will PPHM Continue To Move Higher? Find out via this report
First Horizon National Corporation (NYSE:FHN) showed 9.54 million shares in volume during the last trading session, while the average trading volume remained 2.59 million shares. The stock kicked off its trading session at $12.22 and closed at $12.27 after rallied 0.25%. First Horizon National Corporation operates as a bank holding company for First Tennessee Bank National Association that provides various financial services in the United States and internationally.
Why Should Investors Buy FHN After The Recent Gain? Just Go Here and Find Out
Galena Biopharma Inc (NASDAQ:GALE) stock traded during its last trading session with the total traded volume of 6.80 million shares versus its average volume of 6.78 million shares. The company opened its trade at the price of $6.378 and its closing price was $6.35 after gained 5.13% for the day. Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care.
For How Long GALE will Fight for Profitability? Read This Trend Analysis report
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)